Isatuximab, sold under the brand name Sarclisa, is a monoclonal antibody (mAb) medication for the treatment of multiple myeloma. The most common side effects...
31 KB (3,186 words) - 02:41, 16 July 2024
epitope amino-acid sequence than does the anti-CD38 monoclonal antibody isatuximab. Daratumumab binds to CD38, causing cells to apoptose via antibody-dependent...
22 KB (1,823 words) - 07:01, 8 August 2024
Many such groupings include one or more of a monoclonal antibody (e.g., isatuximab or daratumumab), an immunomodulatory agent (e.g., lenalidomide or pomalidomide)...
131 KB (13,504 words) - 07:52, 2 September 2024
article incorporates text from this source, which is in the public domain. "Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma...
13 KB (1,060 words) - 05:46, 18 July 2024
of bone marrow Iratumumab mab human CD30 (TNFRSF8) Hodgkin's lymphoma Isatuximab Sarclisa mab chimeric CD38 Y multiple myeloma Iscalimab mab human CD40...
136 KB (4,020 words) - 07:14, 15 August 2024
Elotuzumab Enfortumab vedotin Epcoritamab Inotuzumab ozogamicin Ipilimumab Isatuximab Loncastuximab tesirine Mirvetuximab soravtansine Mogamulizumab Moxetumomab...
12 KB (794 words) - 03:30, 2 September 2024
called "soravtansine" mirvetuximab soravtansine ImmunoGen also developed isatuximab, a monoclonal antibody without linkage to a toxin. ImmunoGen uses its...
9 KB (803 words) - 22:13, 28 August 2024
ozogamicin L01FB02 Moxetumomab pasudotox L01FC01 Daratumumab L01FC02 Isatuximab L01FD01 Trastuzumab L01FD02 Pertuzumab L01FD03 Trastuzumab emtansine L01FD04...
12 KB (877 words) - 15:36, 25 January 2024
CD38-IN-78c Chrysanthemin (Kuromanin) compound 1ai compound 1am Daratumumab Isatuximab Felzartamab (MOR202) apigenin Luteolinidin MK-0159 TNB-738 A gradual increase...
35 KB (3,825 words) - 06:11, 5 June 2024
lenalidomide, pomalidomide, and a monoclonal antibody (daratumumab or isatuximab); nearly all had also undergone hematopoietic stem cell transplantation...
30 KB (2,715 words) - 06:09, 16 July 2024
Elotuzumab Enfortumab vedotin Epcoritamab Inotuzumab ozogamicin Ipilimumab Isatuximab Loncastuximab tesirine Mirvetuximab soravtansine Mogamulizumab Moxetumomab...
12 KB (758 words) - 23:46, 14 March 2024
Ecromeximab§ Ensituximab§ Futuximab§ Girentuximab† Indatuximab ravtansine§ Isatuximab Loncastuximab tesirine Margetuximab Mirvetuximab soravtansine Rituximab#...
5 KB (368 words) - 15:29, 21 August 2024
Ecromeximab§ Ensituximab§ Futuximab§ Girentuximab† Indatuximab ravtansine§ Isatuximab Loncastuximab tesirine Margetuximab Mirvetuximab soravtansine Rituximab#...
3 KB (129 words) - 01:04, 19 July 2023
Ecromeximab§ Ensituximab§ Futuximab§ Girentuximab† Indatuximab ravtansine§ Isatuximab Loncastuximab tesirine Margetuximab Mirvetuximab soravtansine Rituximab#...
4 KB (241 words) - 13:42, 14 July 2024